Domenico Girelli: Continuing Commitment to Rare Disease Research
Domenico Girelli, Full Professor of Internal Medicine at the University of Verona, Director of the Department of Medicine at the University of Verona, and Director of the Internal and Emergency Unit at the University Hospital of Verona, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our commitment to research in rare diseases continues…”
Title: Dapagliflozin in Patients With CKD With Fabry Disease
Authors: Yuri Battaglia, Nicola Vitturi, Giacomo Marchi, Federica Baciga, Federica Caccia, Giorgia Gugelmo, Loris Martinetti, Lucia Federica Stefanelli, Sara Torresani, Antonio Pisani, Eleonora Riccio, Pasquale Esposito, Francesca Viazzi, Cristina Chimenti, Francesca Katiana Martino, Livia Lenzini, Annalisa Sechi, Luca Zanoli, Domenico Girelli, Gian Paolo Fadini, Gianni Carraro
Read the Full Article on Science Direct․
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS